United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

23 Aug 2019
Change (% chg)

HK$0.45 (+1.56%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Li, Zhiming 

Mr. Li Zhiming is an Executive Chairman of the Board, Deputy Secretary of Party Committee of Sinopharm Group Co. Ltd. Mr. Li joined the Company in May 2010 as the vice President, and has served as the President from November 2013 to November 2017, and has served as executive Director since January 2014 and the Chairman and the secretary of Party Committee since March 2017. Mr. Li was the chief legal advisor, the secretary of disciplinary committee, chairman of labor union and the deputy secretary of the Party Committee of the Company from October 2012 to March 2017. He has more than 36 years of working experience, over 32 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Li graduated from the Xinjiang Commerce College with associate degree and a major in finance and accounting in July 1981, and graduated from the economic management discipline of the Urumqi Branch of Xi’an Military Academy with associate degree in July 1997. Mr. Li was qualified as a senior economist and a chief pharmacist. Mr. Li was the deputy director of finance department of Xinjiang New & Special Ethnic Drug Store, deputy general manager and chief accountant of Xinjiang Pharmaceutical Industry and Trade Company, deputy general manager and chief accountant of Xinjiang New & Special Ethnic Drug Corporation, and deputy director of the office of the preparatory and leading group of Xinjiang Pharmaceutical Administration Bureau steering the construction of the group entity from July 1985 to July 1996. Mr. Li was general manager, chairman of the board of directors, secretary of the Party Committee of Xinjiang New & Special Ethnic Drug Corporation, and the director, general manager, vice chairman, chairman, and secretary of the Party Committee of Xinjiang Pharmaceutical Group Company (currently known as Sinopharm Group Xinjiang New & Special Pharmaceutical Co., Ltd.) from July 1996 to February 2016. Mr. Li is currently the director of Sinopharm Industrial Investment Co.,

Basic Compensation

Total Annual Compensation, CNY 6,551,000
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY 21,000
Fiscal Year Total, CNY 6,572,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li


Yong Liu


Qiyu Chen


Xiuchang Jiang


Maisong Cai


Jun Lu

As Of  31 Dec 2017